Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Enorama Pharma Logo
Enorama Pharma Growth Score
88
CB Rank
201884
Heat Score
72
Enorama Pharma is a manufacturer of nicotine chewing gums and pouches used for quitting smoking.
Founded
obfuscation
PublicPost-IPO Debt Malmö, Skane Lan, Sweden1-10 www.enorama.se
Manufacturing
Medical
Pharmaceutical
Overview

Enorama Pharma
Total Funding
obfuscation
Growth Score
88
Heat Score
72

Total Funding
obfuscation
obfuscation
Post-IPO Debt raised
obfuscation
Growth Score88
-3 pts
in past quarter
Heat Score 72
1 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Enorama Pharma

CB Rank
201884
Enorama Pharma is a manufacturer of nicotine chewing gums and pouches used for quitting smoking.
Founded
obfuscation
PublicPost-IPO Debt Malmö, Skane Lan, Sweden1-10 www.enorama.se
Manufacturing
Medical
Pharmaceutical

Funding Rounds

Post-IPO Debt
OBF
in
obfuscation

Details

Legal Name Enorama Pharma AB
Operating Status Active
Stock Symbol  STO:ERMA
Company Type For Profit
Founders  Mats Rönngard
About the Company
Enorama Pharma AB is a Swedish innovative pharmaceutical firm with a focus on Life Science.
Phone Number +46 40 140620
Contact Email info@enorama.se
Predictions & Insights

Growth Insight

See this Growth Insight
Enorama Pharma is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Growth Prediction

See this Growth Prediction

Products & Services

NIC-S Nicotine Pouches
Tobacco-free nicotine pouches available in six flavors and three strengths, designed for consumers seeking alternatives to smoking.
Nicotine Chewing Gum
Oral nicotine chewing gum formulated to aid smoking cessation by delivering nicotine through chewing.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Debt - Enorama Pharma Logo
Post-IPO Debt - Enorama Pharma
1
obfuscation
DS GroupPost-IPO Debt
obfuscation
Post-IPO Debt - Enorama Pharma Logo
Post-IPO Debt - Enorama Pharma
1
obfuscation
DS GroupPost-IPO Debt
obfuscation
Post-IPO Debt - Enorama Pharma Logo
Post-IPO Debt - Enorama Pharma
1
obfuscation
DS GroupPost-IPO Debt
obfuscation
Post-IPO Debt - Enorama Pharma Logo
Post-IPO Debt - Enorama Pharma
1
obfuscation
DS GroupPost-IPO Debt
obfuscation
Post-IPO Debt - Enorama Pharma Logo
Post-IPO Debt - Enorama Pharma
1
obfuscation
DS GroupPost-IPO Debt

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Debt - Enorama Pharma Logo
Post-IPO Debt - Enorama Pharma
1
obfuscation
DS GroupPost-IPO Debt
obfuscation
Post-IPO Debt - Enorama Pharma Logo
Post-IPO Debt - Enorama Pharma
1
obfuscation
DS GroupPost-IPO Debt
obfuscation
Post-IPO Debt - Enorama Pharma Logo
Post-IPO Debt - Enorama Pharma
1
obfuscation
DS GroupPost-IPO Debt
obfuscation
Post-IPO Debt - Enorama Pharma Logo
Post-IPO Debt - Enorama Pharma
1
obfuscation
DS GroupPost-IPO Debt
obfuscation
Post-IPO Debt - Enorama Pharma Logo
Post-IPO Debt - Enorama Pharma
1
obfuscation
DS GroupPost-IPO Debt

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
DS Group Logo
DS Group
Yes
Post-IPO Debt - Enorama Pharma Logo
Post-IPO Debt - Enorama Pharma
—
DS Group Logo
DS Group
Yes
Post-IPO Debt - Enorama Pharma Logo
Post-IPO Debt - Enorama Pharma
—
DS Group Logo
DS Group
Yes
Post-IPO Debt - Enorama Pharma Logo
Post-IPO Debt - Enorama Pharma
—
DS Group Logo
DS Group
Yes
Post-IPO Debt - Enorama Pharma Logo
Post-IPO Debt - Enorama Pharma
—
DS Group Logo
DS Group
Yes
Post-IPO Debt - Enorama Pharma Logo
Post-IPO Debt - Enorama Pharma
—
Market Intelligence
People
View Profiles & Contacts
Headcount 1-10
News

News and Press

News•May 13, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Apr 7, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Mar 17, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Feb 19, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

1,419
109.29%
 in past month

IT Spend

$89.5KThis year, Enorama Pharma is projected to spend $89.5K on IT, according to Aberdeen.

Active Website Tech Count

5Enorama Pharma is actively using 5 technologies for its website, according to BuiltWith. These include Person Schema, Gravatar Profiles, and  Facebook Sharer.

Total IP

20The intellectual property of Enorama Pharma includes 4 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery. Additionally, Enorama Pharma has registered 16 trademarks with the most popular class being 'Pharmaceutical, veterinary and sanitary products', according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Enorama Pharma's headquarters? Enorama Pharma is located in Malmö, Skane Lan, Sweden.Who invested in Enorama Pharma? Enorama Pharma is funded by DS Group.When was the last funding round for Enorama Pharma? Enorama Pharma closed its last funding round on
obfuscation
from a Post-IPO Debt round.Who are Enorama Pharma's competitors? Alternatives and possible competitors to Enorama Pharma may include Snusdaddy, GN Tobacco, and  Swedish Match.How much funding has Enorama Pharma raised to date? Enorama Pharma has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(53d292a 1)
|